This Article Full Text Full Text (PDF) Correction (v39,pe142) All Versions of this Article: 39/1/180    most recent STROKEAHA.107.490631v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dayoub, H. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Dayoub, H. Articles by Faraci, F. M. Related Collections Pathophysiology Genetically altered mice Endothelium/vascular type/nitric oxide

(Stroke. 2008;39:180.)
© 2008 American Heart Association, Inc.

Original Contributions

Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine–Induced Endothelial Dysfunction in the Cerebral Circulation

Hayan Dayoub, MD; Roman N. Rodionov, MD, PhD; Cynthia Lynch, BS; John P. Cooke, MD, PhD; Erland Arning, PhD; Teodoro Bottiglieri, PhD; Steven R. Lentz, MD, PhD Frank M. Faraci, PhD

From the Departments of Internal Medicine (H.D., R.R., C.L., S.R.L., F.M.F.), Neurosurgery (H.D.), and Pharmacology (F.M.F.), University of Iowa Carver College of Medicine, Iowa City, Iowa; the Department of Cardiovascular Medicine (J.P.C.), Stanford University, Stanford, Calif; the Baylor Institute of Metabolic Disease (E.A., T.B.), Dallas, Tex; and the Veterans Affairs Medical Center (F.M.F.), Iowa City, Iowa.

Correspondence to Frank M. Faraci, PhD, Department of Internal Medicine, E318-2-GH, University of Iowa, Carver College of Medicine, Iowa City, IA 52242-1081. E-mail frank-faraci{at}uiowa.edu

Background and Purpose— Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). An elevation of plasma ADMA levels is associated with cardiovascular disease. ADMA is hydrolyzed by dimethylarginine dimethylaminohydrolases (DDAHs). The goal of this study was to determine whether overexpression of human DDAH-1 in transgenic (DDAH-1–Tg) mice inhibits the vascular effects of ADMA.

Methods— Using nontransgenic (non-Tg) and DDAH-1–Tg mice, we compared responses of the carotid artery and aorta (in vitro) and of the cerebral arterioles (in vivo) in the absence or presence of ADMA. DDAH-1 expression and plasma levels of ADMA were also measured.

Results— Western blotting indicated that vascular expression of DDAH-1 was increased markedly in DDAH-1–Tg mice. Plasma levels of ADMA were reduced by 50% in DDAH-1–Tg mice compared with non-Tg mice (0.19±0.02 vs 0.37±0.04 µmol/L, P<0.05). Contraction of the aorta to nitro-L-arginine methyl ester (an inhibitor of NOS), an index of basal production of NO, was increased in DDAH-1–Tg mice compared with controls (50±4% vs 34±4%, P<0.05). Relaxation of the carotid artery to acetylcholine (an endothelium-dependent agonist) was enhanced in DDAH-1–Tg animals compared with control mice (relaxation of 74±6% vs 59±5%, respectively, in response to 10 µmol/L acetylcholine, P<0.05). ADMA (100 µmol/L) impaired the vascular response to acetylcholine in both non-Tg and DDAH-1–Tg mice, but the relative difference between the 2 strains remained. Responses to the endothelium-independent NO donor nitroprusside were similar in all groups. In vivo, ADMA (10 µmol/L) reduced responses of the cerebral arterioles to acetylcholine by 70% in non-Tg mice (P<0.05), and this inhibitory effect was largely absent in DDAH-1–Tg mice.

Conclusions— These findings provide the first evidence that overexpression of DDAH-1 increases basal levels of vascular NO and protects against ADMA-induced endothelial dysfunction in the cerebral circulation.

Key Words: carotid arteries • cerebral arterioles • endothelium • genetically altered mice • nitric oxide

This article has been cited by other articles:

				N. Toda, K. Ayajiki, and T. Okamura Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97. [Abstract] [Full Text] [PDF]